Basis of Presentation (Details Textual)
|
1 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 2 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 2 Months Ended | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2010
VEF
|
Dec. 31, 2009
USD ($)
|
Dec. 31, 2009
VEF
|
Dec. 31, 2011
USD ($)
Y
|
Dec. 31, 2010
USD ($)
|
Dec. 31, 2009
USD ($)
|
Dec. 31, 2011
VEF
|
May 10, 2011
|
Apr. 28, 2011
|
Dec. 31, 2010
VEF
|
Dec. 31, 2008
USD ($)
|
Jun. 30, 2010
Herbalife Venezuela's [Member]
USD ($)
|
Feb. 28, 2011
Herbalife Venezuela's [Member]
USD ($)
|
Feb. 28, 2011
Herbalife Venezuela's [Member]
VEF
|
Mar. 31, 2011
Herbalife Venezuela's [Member]
USD ($)
|
Jun. 30, 2010
Herbalife Venezuela's [Member]
USD ($)
|
Dec. 31, 2009
Herbalife Venezuela's [Member]
USD ($)
|
Dec. 31, 2011
Herbalife Venezuela's [Member]
USD ($)
|
Dec. 31, 2010
Herbalife Venezuela's [Member]
USD ($)
|
Dec. 31, 2009
Herbalife Venezuela's [Member]
USD ($)
|
Dec. 31, 2009
Herbalife Venezuela's [Member]
VEF
|
Dec. 31, 2011
Herbalife Venezuela's [Member]
VEF
|
Dec. 31, 2010
Herbalife Venezuela's [Member]
VEF
|
Jun. 30, 2010
Herbalife Venezuela's [Member]
VEF
|
May 31, 2010
Herbalife Venezuela's [Member]
VEF
|
Jun. 30, 2010
Herbalife Venezuela's [Member]
General and Administrative Expense [Member]
USD ($)
|
Dec. 31, 2010
Herbalife Venezuela's [Member]
General and Administrative Expense [Member]
USD ($)
|
Feb. 28, 2011
Herbalife Venezuela's [Member]
United States [Member]
USD ($)
|
Feb. 28, 2011
Herbalife Venezuela's [Member]
United States [Member]
VEF
|
|
Basis of Presentation (Textual) [Abstract] | |||||||||||||||||||||||||||||
Conversion resulted net pre-tax loss | $ 11,400,000 | $ 7,300,000 | $ 7,700,000 | $ 15,100,000 | |||||||||||||||||||||||||
SITME can only be used for amount per day | 50,000 | ||||||||||||||||||||||||||||
SITME can only be used for amount Per Month | 350,000 | ||||||||||||||||||||||||||||
Period to use denominated bonds | 90 days | ||||||||||||||||||||||||||||
Subsidiary's net sales to Company's consolidated net sales, percentage | less than 2% | less than 2% | less than 4 % | less than 4 % | |||||||||||||||||||||||||
Subsidiary's total assets to Company's consolidated total assets, percentage | less than 3% | less than 3% | |||||||||||||||||||||||||||
Net foreign exchange loss (pre-tax) | 1,300,000 | 1,200,000 | |||||||||||||||||||||||||||
Payments to acquire US denominated bonds | 16,300,000 | 86,000,000 | |||||||||||||||||||||||||||
Proceeds from sale of US denominated bonds | 15,000,000 | ||||||||||||||||||||||||||||
Average effective conversion rate | 5.7 | 5.4 | |||||||||||||||||||||||||||
Intercompany shipment payables settled | 13,600,000 | ||||||||||||||||||||||||||||
Incremental costs related to the importation of products | 12,700,000 | 18,800,000 | |||||||||||||||||||||||||||
Foreign currency denominated cash and cash equivalents | 5,900,000 | 5,900,000 | |||||||||||||||||||||||||||
Market exchange rate for remeasurement of cash and cash equivalents | 5.9 | ||||||||||||||||||||||||||||
Official exchange rate for translation of cash and cash equivalents | 2.15 | ||||||||||||||||||||||||||||
Cash and cash equivalents | 150,801,000 | 258,775,000 | 190,550,000 | 150,801,000 | 150,847,000 | 34,200,000 | 34,200,000 | 34,800,000 | 24,600,000 | ||||||||||||||||||||
Part of cash and cash equivalent reduced | 12,500,000 | 12,500,000 | |||||||||||||||||||||||||||
Cash and cash equivalents dominated in domestic currency | 15,800,000 | 15,800,000 | |||||||||||||||||||||||||||
Cash and cash equivalents dominated in foreign currency | 18,400,000 | 18,400,000 | |||||||||||||||||||||||||||
Amount of cash and cash equivalent greater than the amount in domestic currency denominated bank account | 9,900,000 | 9,900,000 | 9,900,000 | 9,900,000 | |||||||||||||||||||||||||
SITME rate for remeasurement | 5.3 | 5.3 | 5.3 | 5.3 | |||||||||||||||||||||||||
Net monetary Bolivar denominated assets and liabilities | 26,800,000 | 19,400,000 | |||||||||||||||||||||||||||
Face value of US denominated bonds | 20,000,000 | ||||||||||||||||||||||||||||
Percentage of cumulative inflation rate | 100.00% | 100.00% | 100.00% | ||||||||||||||||||||||||||
Net (post-tax) foreign exchange gain | 2,600,000 | ||||||||||||||||||||||||||||
Parallel market rate | 8.3 | ||||||||||||||||||||||||||||
Increase in cash & cash equivalents as result of SITME rate | 5,200,000 | ||||||||||||||||||||||||||||
Outstanding intercompany shipment payable balance | 100,000 | 2,600,000 | |||||||||||||||||||||||||||
Official conversion rate for non-essential items | 4.3 | ||||||||||||||||||||||||||||
Official conversion rate for essential items | 2.6 | ||||||||||||||||||||||||||||
Net foreign exchange gain (pre-tax) | 4,000,000 | 5,800,000 | |||||||||||||||||||||||||||
Intercompany dividend payable | 2,500,000 | ||||||||||||||||||||||||||||
Basis of Presentation (Additional Textual) [Abstract] | |||||||||||||||||||||||||||||
Basis of shares approved by shareholders | Two-for-one stock split | ||||||||||||||||||||||||||||
Number of additional shares distributed to Company's shareholders for each share | 1 | ||||||||||||||||||||||||||||
Receivables from credit card company | 65,100,000 | 51,400,000 | |||||||||||||||||||||||||||
Depreciation and amortization of property, plant and equipment | 68,900,000 | 67,700,000 | 62,200,000 | ||||||||||||||||||||||||||
Marketing related intangibles and other intangible assets, net | 310,000,000 | 310,000,000 | 310,000,000 | 310,000,000 | |||||||||||||||||||||||||
Goodwill | 102,500,000 | 105,490,000 | 102,899,000 | 102,500,000 | |||||||||||||||||||||||||
Increase in goodwill due to acquisitions | 2,600,000 | 400,000 | |||||||||||||||||||||||||||
Intangible assets with finite lives | 1,700,000 | 1,700,000 | 800,000 | 1,700,000 | |||||||||||||||||||||||||
Amortization expense for finite life intangible assets | 600,000 | 900,000 | 200,000 | ||||||||||||||||||||||||||
Future Amortization Expense for 2012 | 600,000 | ||||||||||||||||||||||||||||
Future Amortization Expense for 2013 | 400,000 | ||||||||||||||||||||||||||||
Future Amortization Expense for 2014 | 300,000 | ||||||||||||||||||||||||||||
Future Amortization Expense for 2015 | 300,000 | ||||||||||||||||||||||||||||
Future Amortization Expense for 2016 | 100,000 | ||||||||||||||||||||||||||||
Warrant outstanding | 500,000 | ||||||||||||||||||||||||||||
Exercise price of warrants | $ 7.75 | ||||||||||||||||||||||||||||
Equity Grants, Outstanding | 2,100,000 | 1,500,000 | 5,600,000 | ||||||||||||||||||||||||||
Period of receiving anticipated returns | 12 months | ||||||||||||||||||||||||||||
Amount for exchange foreign currency into domestic currency | $ 19,500,000 | 105,000,000 | |||||||||||||||||||||||||||
Intangible assets with finite lives are amortized over their expected lives | 5 |